Molycorp initiated the start-up of its new Mill, Flotation Separator, and Paste Tailings Facility at Mountain Pass.
The Company announced a 36% expansion of its proven and probable rare earth reserves at Mountain Pass under the SEC 'Industry Guide 7? methodology, confirming 18.4 million short tons of rare earth ore at an average ore grade of 7.98%.
Molycorp recorded Q1 GAAP net sales of $84.5 million, up 221% over Q1 2011 net sales of $26.3 million, and recorded Q1 2012 gross sales of $89.5 million.
First quarter revenues at Mountain Pass increased 69% over first quarter 2011 levels to $44.5 million, based on 586 metric tons (mt) of REO equivalent. Consolidated sales volume across all segments was 719 mt of REO equivalent and 75 mt of rare metals.
The Company reported a Q1 GAAP loss of $0.07 per diluted share and adjusted earnings of $0.18 per diluted share, taking into account certain non-cash, out-of-ordinary business expenses, and other operational expansion items.
The Company also reported that its planned acquisition of Neo Material Technologies is proceeding on schedule and is expected to close as planned in Q2/Q3 of this year.
Molycorp, Inc. (NYSE: MCP) ('Molycorp? or the 'Company?) today announced financial and operating results for the first quarter 2012.
'The start of 2012 has been tremendously productive as we continue to hit each of our major milestones on the path to completion of Project Phoenix,? said Mark Smith, President and Chief Executive Officer. 'The start up of our concentrate production circuit is a major accomplishment for the Company. I could not be more proud of the effort the Molycorp family has devoted to get to this point, especially in light of the more than 2.3 million hours we have worked in the construction of Project Phoenix without a lost time incident. As we continue to build out Project Phoenix to its full Phase 1 and Phase 2 capacities, we remain on track to establish one of the world′s premiere and fully integrated rare earths and rare metals companies.?
Smith continued, 'We expanded our sales of XSORBX? during the quarter, and we look forward to the opportunities and potential synergies that will arise from our pending acquisition of Neo Material Technologies.'
QUARTERLY RESULTS
Quarterly net sales were $84.5 million, significantly higher than $26.3 million in the first quarter of 2011. Molycorp Silmet (Sillamäe, Estonia) and Molycorp Metals & Alloys (Tolleson, Arizona) were acquired during the second quarter of 2011, which contributed revenue during Q1 2012. Even though the first quarter is traditionally soft due to the impact of the extended Chinese New Year holiday, we were able to achieve significantly higher revenue this quarter versus the first quarter of 2011.
Gross profit was $31.0 million during the quarter, compared to gross profit of $9.6 million during the prior year period. Gross margin of 36.7% increased 23 basis points from the prior year period.
Molycorp′s first quarter GAAP ?earnings attributable to common stockholders was negative $6.3 million, or a loss of $0.07 per diluted share. Adjusted earnings of $0.18 per diluted share reflects certain non-cash, out-of-ordinary, and business expansion items as compared to U.S. GAAP earnings per share (e.g. a one-time non-cash expense of $6.6 million related to a foreign currency forward contract, $6.6 million in consolidated inventory write-downs, and $2.5 million related to bad debt expense).
FIRST QUARTER 2012 MILESTONE ACHIEVEMENTS
Molycorp continued its steady progress in achieving a number of strategic business and operational milestones during the year. To date in 2012, Molycorp succeeded in the following:
Start-up of its new Mill, Flotation Separator, and Paste Tailings Facility at Mountain Pass, which completes the rare earth concentrate production circuit of Project Phoenix and initiates the production of rare earth concentrate via the following:
Mining of fresh rare earth ore at a daily rate of 2,800 short tons, four days per week.
Crushing and blending of fresh ore.
Start up of milling and flotation of fresh ore to produce rare earth concentrate, to be followed by processing of mine tailings in its Paste Tailings Plant and permanent disposal of mine paste tailings in a fully permitted, on-site facility.
Expanded by 36% its proven and probable reserves of rare earth minerals at Mountain Pass. The independent analysis used the SEC 'Industry Guide 7? methodology and confirmed 18.4 million short tons of rare earth ore at an average ore grade of 7.98%.
Signed a three-year take-or-pay agreement for the annual sale of 100 mt of proprietary XSORBX? water purification products into the recreational water markets. This single agreement will increase Molycorp′s 2012 XSORBX? sales by 81% as compared to all XSORBX? sales completed during 2011.
Announced an agreement to acquire Neo Material Technologies. The transaction, which is proceeding on schedule and is expected to close as planned in Q2/Q3 of this year, subject to the satisfaction of certain closing conditions, will create the world′s most integrated rare earth producer, combining a world-class rare earth resource with the world′s leading producer of value-added rare earth products.
Completed the $390 million capital investment from Molymet.
2012 OUTLOOK
As of May 10, 2012, the Company is re-affirming its annual production of REO equivalent products to be in a range of 8,000 mt to 10,000 mt for the full year across all of its facilities. The Company continues to believe it is well positioned for year-over-year sales growth, given existing customer orders and a growing pipeline of global business opportunities.
As indicated in the previous quarter′s financial results call, the Company conducted and completed an extensive formal review of the Project Phoenix capital expenditure budget. The result of that analysis showed that the Company anticipates no material changes to its Project Phoenix EPC (engineering, procurement and construction) capital budget of $895 million, assuming that the measures it has implemented to mitigate certain adverse cost trends are successful and there are no unanticipated project close out events. Certain additional capital expenditures for other capital projects related to operations at Mountain Pass are expected to total approximately $105 million. These Mountain Pass operations capital projects are covered in the Company′s annual operating plans. To date, $673.5 million has been spent toward Project Phoenix and these other operations-related capital projects. The Company continues to generate positive cash flow from operations, maintain sufficient working capital to execute on its stated strategy, and its balance sheet remains strong.
The Company also is reiterating its prior guidance related to cost of goods sold (COGS) related to Project Phoenix ramping, as well as its stated higher production costs on a consolidated basis. These incremental costs are expected to normalize moving into 2013 as the Company reaches its Phase 1 and Phase 2 production levels.
Commenting on recent market conditions, Smith said: 'It appears the highly volatile pricing environment we experienced in 2011 has moderated, and that is a very positive development for our business. Customer orders are steadily picking up across the industry and pricing has not only stabilized but has increased in some products. We continue to strengthen the reliability of our overall supply chain through Project Phoenix, and we are positioned to broaden and expand that supply chain through our proposed acquisition of Neo Materials. While this year remains a year of transition, we are confident that we are on target to build one of the world's leading, fully integrated rare earths and rare metals companies.?
Smith added: 'Successful execution of our stated strategy should lead to meaningful growth and profitability in the years ahead, and we remain fully committed to enhancing long-term sustainable value for our customers, partners, employees and our shareholders.'
CONFERENCE CALL TODAY AT 4:30 P.M. EASTERN
Molycorp will conduct a conference call today to discuss these results at 4:30 p.m. EDT, hosted by Mark Smith, Chief Executive Officer, and Jim Allen, Chief Financial Officer. Investors interested in participating in the live call from the U.S. should dial +1 (866) 362-4829 and reference passcode number 71439698. Those calling from outside the U.S. should dial +1 (617) 597-5346 and use the same confirmation number. A telephone replay will be available approximately two hours after the call concludes through May 17, 2012 by dialing +1 (888) 286-8010 from the U.S., or +1 (617) 801-6888 from international locations, and entering passcode: 78258730.
(In thousands, except share and per share amounts)
?
?
?
?
?
?
March 31, 2012
December 31, 2011
ASSETS
Current assets:
Cash and cash equivalents
$
609,794
$
418,855
Trade accounts receivable, net
50,715
70,679
Inventory
110,487
111,943
Deferred charges
6,862
7,318
Deferred tax assets
2,049
-
Prepaid income taxes
9,467
10,514
Prepaid expenses and other assets
7,302
?
19,735
?
Total current assets
796,676
?
639,044
?
?
Non-current assets:
Deposits
$
23,277
$
23,286
Property, plant and equipment, net
827,716
561,628
Inventory
10,200
4,362
Intangible assets, net
3,084
3,072
Investments
23,608
20,000
Goodwill
3,432
3,432
Other assets
760
?
301
?
Total non-current assets
892,077
?
616,081
?
Total assets
$
1,688,753
?
$
1,255,125
?
?
LIABILITIES AND EQUITY
Current liabilities:
Trade accounts payable
$
203,986
$
161,587
Accrued expenses
15,502
12,898
Deferred tax liabilities
-
1,356
Debt
1,383
1,516
Short-term borrowing - related party
-
870
Current portion of asset retirement obligation
1,552
?
396
?
Total current liabilities
222,423
?
178,623
?
?
Non-current liabilities:
Asset retirement obligation
$
16,035
$
15,145
Deferred tax liabilities
18,580
18,899
Debt
197,917
196,545
Other non-current liabilities
863
?
683
?
Total non-current liabilities
233,393
?
231,272
?
Total liabilities
$
455,816
?
$
409,895
?
?
Stockholders' equity:
Common stock, $0.001 par value; 350,000,000 shares authorized
at March 31, 2012
96
84
Preferred stock, $0.001 par value; 5,000,000 shares authorized
at March 31, 2012
2
2
Additional paid-in capital
1,230,036
838,547
Accumulated other comprehensive loss
(5,951
)
(8,481
)
Surplus accumulated during the development stage
8,754
?
15,078
?
Total stockholders' equity
1,232,937
?
845,230
?
Total liabilities and stockholders' equity
$
1,688,753
?
$
1,255,125
?
?
TABLE 2: INCOME STATEMENT
MOLYCORP, INC.
(A Company in the Development Stage)
Consolidated Statements of Operations and Comprehensive Income
(In thousands, except share and per share amounts)
?
?
?
?
?
?
?
?
?
?
Total from
Three Months Ended
June 12, 2008
March 31,
(Inception) Through
2012
2011
March 31, 2012
Sales
$
84,470
$
26,261
$
525,688
Operating costs and expenses:
Cost of goods sold
(53,443
)
(16,677
)
(303,736
)
Selling, general and administrative
(31,214
)
(11,238
)
(158,778
)
Depreciation and amortization
(107
)
(83
)
(1,369
)
Accretion expense
(251
)
(234
)
(3,374
)
Operating (loss) income
(545
)
(1,971
)
58,431
?
?
Other income (expense):
Other (expense) income
(6,578
)
(168
)
(6,341
)
Foreign currency transaction gains (losses), net
1,604
?
-
(3,811
)
Interest income (expense), net
85
?
140
?
(238
)
(4,889
)
(28
)
(10,390
)
(Loss) income before income taxes and equity earnings
(5,434
)
(1,999
)
48,041
Income tax benefit (expense)
2,183
(199
)
(26,393
)
Equity in results of affiliates
(227
)
-
?
(227
)
Net (loss) income
$
(3,478
)
$
(2,198
)
$
21,421
?
?
Net (loss) income
$
(3,478
)
$
(2,198
)
$
21,421
Other comprehensive income:
Foreign currency translation adjustments
2,530
?
-
?
(5,951
)
Comprehensive (loss) income
$
(948
)
$
(2,198
)
$
15,470
?
?
Weighted average shares outstanding
(Common shares)
Basic
87,006,460
?
82,253,700
?
60,086,657
?
Diluted
87,006,460
?
82,253,700
?
60,087,803
?
(Loss) income per share of common stock :
Basic
$
(0.07
)
$
(0.04
)
$
0.14
?
Diluted
$
(0.07
)
$
(0.04
)
$
0.14
?
?
TABLE 3: STATEMENT OF CASH FLOWS
MOLYCORP, INC
(A Company in the Development Stage)
Consolidated Statements of Cash Flows (Unaudited)
(In thousands)
?
?
?
?
?
?
?
?
?
Total from
June 12, 2008
March 31,
March 31,
(Inception) Through
2012
2011
March 31, 2012
Cash flows from operating activities:
Net (loss) income
$
(3,478
)
$
(2,198
)
$
21,421
?
Adjustments to reconcile net (loss) income to net cash provided by
operating activities:
Depreciation, amortization and accretion
3,836
2,334
32,751
Deferred income tax benefit
(3,725
)
-
(801
)
Inventory write-downs
6,563
630
32,356
Stock-based compensation expense
825
2,934
34,626
Foreign currency transaction losses, net
(1,668
)
-
3,747
Unrealized loss on derivatives
6,641
-
6,643
Allowance for doubtful accounts
2,500
-
2,500
Other operating adjustments and write-downs
154
-
5,141
Net change in operating assets and liabilities
4,379
?
1,503
?
(137,821
)
Net cash provided by operating activities
16,027
?
5,203
?
563
?
Cash flows from investing activities:
Acquisition of the Molycorp Mountain Pass facility
-
-
(82,150
)
Cash paid in connection with acquisitions, net of cash acquired
-
-
(30,023
)
Investment in joint venture
(3,836
)
-
(3,836
)
Cash paid to acquire non-marketable securities
-
-
(20,000
)
Deposits
(459
)
(1,500
)
(23,762
)
Capital expenditures
(206,463
)
(26,345
)
(549,378
)
Other investing activities
2
?
-
?
9,521
?
Net cash used in investing activities
(210,756
)
(27,845
)
(699,628
)
Cash flows provided by financing activities:
Capital contributions
390,225
-
515,229
Repayments of short-term borrowings - related party
(870
)
(935
)
(5,127
)
Repayments of debt
(777
)
-
(5,205
)
Net proceeds from sale of common stock in conjunction with
-
the initial public offering
-
-
378,633
Net proceeds from sale of preferred stock
-
199,642
199,642
Net proceeds from sale of convertible notes
-
-
223,100
Payment of preferred dividends
(2,846
)
-
(11,861
)
Proceeds from short-term borrowings - related party
-
-
11,645
Proceeds from debt
-
-
5,131
Other financing activities
(132
)
-
?
34
?
Net cash provided by financing activities
385,600
198,707
1,311,221
Effect of exchange rate changes on cash
68
?
-
?
(2,362
)
Net change in cash and cash equivalents
190,939
176,065
609,794
Cash and cash equivalents at beginning of the period
418,855
?
316,430
?
-
?
Cash and cash equivalents at end of period
$
609,794
?
$
492,495
?
$
609,794
?
?
TABLE 4: SEGMENT INFORMATION
?
?
?
?
Molycorp Mountain Pass
?
?
?
?
Molycorp Silmet
?
?
?
?
MMA
?
?
?
?
Other
?
?
?
?
Eliminations
?
?
?
?
Total Molycorp, Inc.
Three Months Ended March 31, 2012 (In thousands)
?
?
Sales:
External
$
44,478
$
21,036
$
18,956
$
-
$
84,470
Intersegment
?
1,832
?
?
3,210
?
?
-
?
?
-
?
$
(5,042
)
-
Total sales
46,310
24,246
18,956
-
Cost of goods sold
(18,846
)
(34,774
)
(18,632
)
-
18,809
(53,443
)
Selling, general and administrative expenses
(29,079
)
(1,714
)
(457
)
(273
)
309
(31,214
)
Depreciation, amortization and accretion expense
?
(334
)
?
-
?
?
-
?
?
(24
)
?
-
?
?
(358
)
Operating (loss) income
(1,949
)
(12,242
)
(133
)
(297
)
14,076
(545
)
Other (expense) income
?
(6,444
)
?
1,579
?
?
(4
)
?
(20
)
?
-
?
?
(4,889
)
Loss before income taxes and equity earnings
$
(8,393
)
$
(10,663
)
$
(137
)
$
(317
)
$
14,076
?
$
(5,434
)
Total assets at March 31, 2012
$
1,675,653
?
$
100,499
?
$
24,313
?
$
630
?
$
(112,342
)
$
1,688,753
?
Capital expenditures (accrual basis excluding capitalized interest)
$
259,438
?
$
2,501
?
$
100
?
$
-
?
$
-
?
$
262,039
?
?
TABLE 5: EARNINGS PER SHARE
?
?
?
?
?
?
?
?
?
?
?
?
Total from
June 12, 2008
Three Months
Three Months
(Inception)
Ended
Ended
Through
March 31,
March 31,
March 31,
(In thousands, except share and per share amounts)
2012
2011
2012
Net (loss) income attributable to Molycorp stockholders
$
(3,478
)
$
(2,198
)
$
21,421
Cumulative undeclared and paid dividends on Convertible Preferred Stock
?
(2,846
)
?
(1,423
)
?
(12,808
)
(Loss) income attributable to common stockholders
?
(6,324
)
?
(3,621
)
?
8,613
?
Weighted average common shares outstanding?basic
87,006,460
82,253,700
60,086,657
Basic (loss) income per share
$
(0.07
)
$
(0.04
)
$
0.14
?
?
Weighted average common shares outstanding?diluted
87,006,460
82,253,700
60,087,803
Diluted (loss) income per share
$
(0.07
)
$
(0.04
)
$
0.14
?
?
TABLE 6: PRODUCT REVENUE, VOLUME, ASPS
Product Revenues, Volumes
?
?
?
?
?
?
?
?
?
Three Months Ended March 31,
Revenues (in thousands)
2012
?
?
?
?
2011
REO Equivalent Products
Didymium Products
$
23,033
?
$
4,693
Neodymium Products
2,209
?
-
Praseodymium Products
2,721
?
69
Lanthanum Products
20,838
?
11,466
Cerium Products
2,694
?
9,053
Other REO Products
109
?
980
Rare Earth Alloys (NdFeB, SmCo)
?
16,728
?
?
?
?
?
-
Subtotal REO Equivalent
68,332
26,261
?
Rare Metals (Nb, Ta)
13,716
-
Other
?
2,422
?
?
?
?
?
-
Total Net Revenues
$
84,470
$
26,261
?
?
Three Months Ended March 31,
Volumes (in metric tons)
2012
?
?
?
?
2011
REO Equivalent Products
Didymium Products
145
?
48
Neodymium Products
12
?
-
Praseodymium Products
23
?
1
Lanthanum Products
424
?
498
Cerium Products
70
?
137
Other REO Products
5
?
12
Rare Earth Alloys (NdFeB, SmCo)
?
39
?
?
?
?
?
-
Subtotal REO Equivalent
719
696
?
Rare Metals (Nb, Ta)
75
?
-
Other
?
135
?
?
?
?
?
-
Total Product Volumes
nm
nm
?
?
Three Months Ended March 31,
Avg Selling Price per kg
2012
?
?
?
?
2011
REO Equivalent Products
Didymium Products
$
159
$
98
Neodymium Products
184
-
Praseodymium Products
117
69
Lanthanum Products
49
23
Cerium Products
38
66
Other REO Products
20
82
Rare Earth Alloys (NdFeB, SmCo)
?
428
?
?
?
?
na
Subtotal REO Equivalent
$
95
$
38
?
Rare Metals (Nb, Ta)
$
183
na
Other
?
18
?
?
?
?
na
Average selling price
nm
nm
?
nm = not material
Note Rare Earth Alloy volume of 96 mt contain 39 mt of REO equivelents
?
TABLE 7: NON-GAAP ADJUSTED NET INCOME RECONCILIATION
Molycorp, Inc.
?
?
?
?
?
?
?
?
Non-GAAP financial measures
Adjusted Net Income (Loss)
?
(in thousands, except per share data)
Three months ended
Three months ended
March 31,
March 31,
2012
2011
Net income (loss) attributable to Molycorp stockholders
$
(3,478
)
$
(2,198
)
Certain non-cash and other items:
Stock-based compensation
825
2,934
Inventory write-downs
6,563
630
Loss on Foreign currency hedge
6,643
-
Bad debt expense
2,500
-
?
Out of the ordinary items:
Water removal
3,520
Revenue sharing agreement
-
393
Project Phoenix non-capitalizable costs
5,336
?
Business Expansion items:
Due diligence and other transaction costs
3,289
1,906
Other business expansion expenses
3,159
987
Income tax effect of above adjustments
?
(10,052
)
?
(2,671
)
Adjusted net income (loss)
$
18,304
$
1,980
Cumulative paid and undeclared dividends on preferred stock
(2,846
)
(1,423
)
Effect of dilutive 3.25% Convertible Notes
?
-
?
?
-
?
Adjusted net income (loss) attributed to common stockholders for dilutive EPS purposes
?
15,458
?
?
557
?
Weighted average diluted shares outstanding
?
87,006,460
?
?
82,253,700
?
Adjusted diluted net income (loss) per share
$
0.18
?
$
0.01
?
?
NON-GAAP ADJUSTED NET INCOME
Adjusted EPS is a non-GAAP measure that excludes certain non-cash items and other out-of-ordinary operational and business expansion items. The Company′s management believes adjusting out these items, including but not limited to purchase accounting adjustments, stock-based compensation, out-of-ordinary expenses/income and other miscellaneous charges is useful to investors because it provides an overall understanding of the Company′s historical financial performance and future prospects. Management believes adjusted EPS is an indication of the Company′s base-line performance. Exclusion of these items permits evaluation and comparison of results for the Company′s core business operations, and it is on this basis that management internally assesses the Company′s performance.
TABLE 8: NON-GAAP GROSS SALES
?
?
?
Molycorp Mountain Pass
?
?
?
Molycorp Silmet
?
?
?
MMA
?
?
?
Total Molycorp, Inc.
Three Months Ended March 31, 2012 (In thousands)
?
Sales:
Sales net of intercompany transfers
$
44,478
$
21,036
$
18,956
$
84,470
Intersegment
?
1,832
?
3,210
?
-
?
-
Total gross sales
$
46,310
$
24,246
$
18,956
$
89,512
?
?
Molycorp Mountain Pass
?
Molycorp Sillamäe
?
MMA
Total Molycorp, Inc.
Three Months Ended December 31, 2011 (In thousands)
Sales:
Sales net of intercompany transfers
$
26,261
nm
nm
$
26,261
Intersegment
?
-
nm
nm
?
Total gross sales
$
26,261
nm
nm
$
26,261
?
Note Molycorp Sillamet and MMA were acquired during the second quarter of 2011.
?
NON-GAAP GROSS SALES
Gross sales is a non-GAAP measure that is included to provide additional detail on segment operations and vertical integration strategy. The Company′s management believes this presentation provides a better understanding of the performance of each operating segment in terms of production volumes, inventory allocation, and costs.
ABOUT MOLYCORP
With offices in the U.S., Europe, and Japan, Molycorp, Inc. is one of the world's leading rare earths and rare metals companies. Fully integrated across the rare earth mine-to-magnets supply chain, it currently produces rare earth oxides at its flagship rare earth mine and processing facility at Mountain Pass, California, as well as rare earth metals, rare earth alloys, and the rare metals niobium and tantalum. Through its joint venture with Daido Steel and Mitsubishi Corporation, Molycorp expects to begin manufacturing next-generation, sintered neodymium-iron-boron (NdFeB) permanent rare earth magnets in 2013. The rare earths and rare metals that Molycorp produces are critical inputs in existing and emerging applications including: clean energy technologies, such as hybrid and electric vehicles and wind power turbines; multiple high-tech uses, including fiber optics, lasers and hard disk drives; numerous defense applications, such as guidance and control systems and global positioning systems; advanced water treatment technology for use in industrial, military and outdoor recreation applications; and other technologies. For more information please visit
This release contains forward-looking statements that represent Molycorp′s beliefs, projections and predictions about future events or Molycorp′s future performance, including those regarding the proposed acquisition of Neo Materials. Forward-looking statements can be identified by terminology such as 'may,? 'will,? 'would,? 'could,? 'should,? 'expect,? 'intend,? 'plan,? 'anticipate,? 'believe,? 'estimate,? 'predict,? 'potential,? 'continue? or the negative of these terms or other similar expressions or phrases. These forward-looking statements are necessarily subjective and involve known and unknown risks, uncertainties and other important factors that could cause Molycorp′s actual results, performance or achievements or industry results to differ materially from any future results, performance or achievement described in or implied by such statements.
Factors that may cause actual results to differ materially from expected results described in forward-looking statements include, but are not limited to: the time required to consummate the proposed acquisition of Neo Material; the satisfaction or waiver of conditions in the arrangement agreement related to the proposed acquisition of Neo Material; any material adverse changes in the affairs of Neo Material; the ability to obtain required shareholder, regulatory, court or other third-party approvals and consents and otherwise consummate the proposed acquisition of Neo Material; Molycorp′s ability to achieve the strategic and other objectives related to the proposed acquisition, including any expected synergies; Molycorp′s ability to successfully integrate Neo Material and achieve the expected results of the acquisition; Molycorp′s ability to successfully obtain permanent financing to replace the bridge financing in connection with the acquisition of Neo Material; Molycorp′s ability to secure additional capital to implement its business plans; Molycorp′s ability to complete its initial modernization and expansion efforts, including the accelerated start-up of the Mountain Pass facility, which management refers to as Project Phoenix Phase 1, and the second phase capacity expansion plan, which management refer to as Project Phoenix Phase 2, and reach full planned production rates for REOs and other planned downstream products, in each case within the projected timeframe; the success of Molycorp′s cost mitigation efforts in connection with Project Phoenix, which, if unsuccessful, might cause its costs to exceed budget; the final costs of the Project Phoenix Phase 1, including with accelerated start-up of the Mountain Pass facility, and Project Phoenix Phase 2, which may differ from estimated costs; uncertainties regarding global supply and demand for rare earths materials; Molycorp′s ability to successfully integrate recently acquired businesses; uncertainties associated with Molycorp′s reserve estimates and non-reserve deposit information, including estimated mine life and annual production; uncertainties related to feasibility studies that provide estimates of expected or anticipated costs, expenditures and economic returns; and REO prices, production costs and other expenses for operations, which are subject to fluctuation; Molycorp′s ability to maintain appropriate relations with unions and employees; Molycorp′s ability to successfully implement its 'mine-to-magnets? strategy; environmental laws, regulations and permits affecting Molycorp′s business, directly and indirectly, including, among others, those relating to mine reclamation and restoration, climate change, emissions to the air and water and human exposure to hazardous substances used, released or disposed of by Molycorp; and uncertainties associated with unanticipated geological conditions related to mining.
For more information regarding these and other risks and uncertainties that Molycorp may face, see the section entitled 'Risk Factors? of the Company′s Annual Report on Form 10-K for the year ended December 31, 2011 and of the Company′s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2011. Any forward-looking statement contained in this press release or the Annual Report on Form 10-K or the Quarterly Report on Form 10-Q reflects Molycorp′s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Molycorp′s operations, operating results, growth strategy and liquidity. You should not place undue reliance on these forward-looking statements because such statements speak only as to the date when made. Molycorp assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future, except as otherwise required by applicable law.